Ipca Laboratories LtdPharmaceuticalsINE571A01038Consolidated₹2009.60+39.30 (+1.99%)Jun-26
Valuation
Market Cap₹50.98K Cr
TTM PE38.92x
Forward PE37.22x
PEG2.63
Book Value₹317.84
P/B6.32x
TTM EPS₹51.63
Fwd EPS₹53.99
TTM Revenue₹10.13K Cr
TTM PAT₹1.38K Cr
TTM EBITDA₹2.23K Cr
TTM EBIT₹1.80K Cr
Last Qtr PAT₹424.27 Cr
Last Qtr EBITDA₹669.51 Cr
Last Qtr EBIT₹558.70 Cr
Profitability
ROE17.05%
ROCE21.37%
TTM NPM13.58%
TTM EBITDA %22.04%
Curr OPM15.08%
Last OPM12.36%
Curr NPM
Last NPM
Curr EPS₹15.84
Last EPS₹11.79
Balance sheet
Equity₹25.37 Cr
Reserve₹8.04K Cr
Total Debt₹749.94 Cr
D/E0.09x
Interest %2.80%
Curr Interest₹11.88 Cr
Price / range
Close₹2009.60
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+1.99%
1W+2.09%
1M+6.77%
3M+30.19%
6M+30.32%
1Y+50.19%
2Y+39.13%
3Y+116.54%
5Y+61.19%
Diwali+43.79%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue2,119.24+21.3%1,814.351,845.181,930.321,746.907,336.75
Other Income17.4229.8817.8221.9225.0294.64
Total Income2,136.66+20.6%1,844.231,8631,952.241,771.927,431.39
Interest5.0410.489.5111.4612.0643.51
Expenditure-1,621.25-14.6%-1,463.96-1,445.78-1,543.93-1,415.17-5,868.84
PBDT000000
EBITDA577.64+42.0%431.18477.48464.71406.921,780.29
Depreciation-74.61-70.31-68.57-66.86-63.13-268.87
EBIT503.03+46.3%360.87408.91397.85343.791,511.42
PBT515.41+44.5%349.85417.22408.31356.751,532.13
Tax-142.12-87.56-113.77-103.57-94.71-399.61
Equity25.3725.3725.37025.3725.37
OPM24.1218.9722.4021.1520.1320.62
Net Profit373.29+42.5%262.29303.45304.74262.041,132.52
NPM17.4714.2216.2915.7914.7915.24
EPS14.71+42.4%10.3411.9612.0110.3344.64

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue7,336.75+9.9%6,677.92+8.3%6,166.46+6.1%5,814.62+7.7%5,399.36+5.1%5,139.16
Other Income94.6471.29111.29111.1956.1362.24
Total Income7,431.39+10.1%6,749.21+7.5%6,277.75+5.9%5,925.81+8.6%5,455.49+4.9%5,201.40
Expenditure-5,868.84-7.3%-5,467.90-2.7%-5,322.23-2.8%-5,175.32-18.5%-4,367.13-14.3%-3,821.44
Interest-43.51-63.04-120.67-43.92-7.21-8.14
PBDT000000
EBITDA1,780.29+16.7%1,525.03+25.9%1,211.38+32.8%911.85-26.7%1,243.54-17.8%1,513.58
Depreciation-268.87-251.97-246.48-228.63-204.10-187.72
EBIT1,511.42+18.7%1,273.06+31.9%964.90+41.2%683.22-34.3%1,039.44-21.6%1,325.86
PBT1,532.13+53.2%999.77+21.6%822.16+9.5%750.49-31.0%1,088.36-21.1%1,379.96
Tax-399.61-349.01-291.75-244.79-217.42-239.19
Equity25.3725.370000
OPM (%)20.6214.8113.0013.0020.0027.00
Net Profit1,132.52+74.0%650.76+22.7%530.41+4.9%505.70-41.9%870.94-23.7%1,140.77
NPM (%)15.249.648.009.0016.0022.00
EPS (Rs)44.64+74.0%25.65+22.7%20.91+7.8%19.39-43.5%34.33-61.9%90.08
CEPS44.6425.6520.9119.3934.3390.08

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue2,788.10+20.8%2,388.482,392.502,556.502,308.859,646.33
Other Income25.2693.7420.1927.8632.66174.45
Total Income2,813.36+20.2%2,482.222,412.692,584.362,341.519,820.78
Interest11.8820.2017.6219.6118.5175.94
Expenditure-2,241.28-11.5%-2,031.95-1,984.36-2,134.52-2,011-8,161.83
PBDT000000
EBITDA669.51+60.8%483.87533.35544.92416.421,978.56
Depreciation-110.81-107.14-107.59-103.33-100.06-418.12
EBIT558.70+76.6%376.73425.76441.59316.361,560.44
PBT572.08+73.1%404.45445.98391.58330.511,572.52
Tax-149.27-95.05-81.93-108.08-96.09-381.15
Equity25.3725.3725.37025.3725.37
OPM20.3316.2918.4815.1514.1216.01
Net Profit424.27+82.2%306.69363.67280.53232.891,183.78
NPM15.0812.3615.0710.859.9512.05
EPS15.84+72.4%11.7912.8611.149.1944.98

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue9,646.33+7.9%8,939.59+16.0%7,705.04+23.4%6,244.32+7.1%5,829.79+7.6%5,419.99
Other Income174.4592.80124.77125.6266.5762.84
Total Income9,820.78+8.7%9,032.39+15.4%7,829.81+22.9%6,369.94+8.0%5,896.36+7.5%5,482.83
Expenditure-8,161.83-6.1%-7,696.20-11.9%-6,879.39-22.3%-5,624.65-18.1%-4,760.64-16.3%-4,093.85
Interest-75.94-84.93-138.27-45.54-7.69-9.04
PBDT000000
EBITDA1,978.56+14.6%1,726.14+30.7%1,321.16+42.6%926.77-29.2%1,309.26-15.2%1,544.35
Depreciation-418.12-397.82-357.24-261.56-232.42-209.17
EBIT1,560.44+17.5%1,328.32+37.8%963.92+44.9%665.21-38.2%1,076.84-19.3%1,335.18
PBT1,572.52+39.0%1,131.14+34.2%842.67+13.1%745.29-34.4%1,135.72-18.2%1,388.98
Tax-381.15-343.61-313.46-253.36-224.27-240.14
Equity25.3725.370000
OPM (%)16.0112.5210.7611.7019.2625.33
Net Profit1,183.78+50.8%785.24+50.2%522.92+9.2%478.99-46.2%889.79-22.0%1,141.14
NPM (%)12.058.696.687.5215.0920.81
EPS (Rs)44.98+54.7%29.08+34.8%21.57+16.1%18.58-46.7%34.85-61.3%90.11
CEPS44.9829.0821.5718.5834.8590.11

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

30
YearTypeAmountEx-Date
2026Final Dividend607 Aug 2026
2025Final Dividend205 Aug 2025
2025Interim Dividend227 Nov 2024
2024Final Dividend206 Aug 2024
2024Interim Dividend222 Nov 2023
2023Interim Dividend422 Nov 2022
2022Interim Dividend822 Nov 2021
2021Interim Dividend813 Nov 2020
2020Interim Dividend518 Feb 2020
2019Final Dividend306 Aug 2019
2018Final Dividend102 Aug 2018
2017Final Dividend127 Jul 2017
2015Final Dividend122 Jul 2015
2014Final Dividend2.518 Jul 2014
2014Interim Dividend2.531 Oct 2013
2013Final Dividend219 Jul 2013
2013Interim Dividend201 Nov 2012
2012Final Dividend1.220 Jul 2012
2012Interim Dividend107 Feb 2012
2012Interim Dividend103 Nov 2011
2011Final Dividend1.218 Jul 2011
2011Interim Dividend101 Feb 2011
2011Interim Dividend128 Oct 2010
2010Final Dividend116 Jul 2010
2010Interim Dividend427 Jan 2010
2010Interim Dividend530 Oct 2009
2009Final Dividend420 Jul 2009
2009Interim Dividend327 Jan 2009
2009Interim Dividend407 Nov 2008
2008Final Dividend4.514 Jul 2008

Bonus

0

No bonus history.

Split

2
YearRatioEx-Date
2022Rs.2/- to Rs.1/-10 Jan 2022
2010Rs.10/- to Rs.2/-22 Mar 2010
Loading company dashboard...
Fetching ratios, charts, and peers